| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $568K | -40.5% | -80.9% |
| SG&A Expense | $2.0M | -8.1% | +5.7% |
| Operating Income | -$2.5M | +18.2% | +47.7% |
| Pre-tax Income | -$938K | +72.1% | +78.1% |
| Income Tax | $0 | — | +100.0% |
| Net Income | -$938K | +72.1% | +72.7% |
| EPS (Basic) | -$0.06 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $16.9M | -15.7% | +11.3% |
| Current Assets | $17.3M | -15.7% | +7.7% |
| Total Assets | $66.6M | -4.6% | +1.9% |
| Current Liabilities | $1.2M | -46.2% | -53.4% |
| Total Liabilities | $3.8M | -39.9% | -59.2% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.9M | -174.5% | — |
| Investing Cash Flow | $0 | — | — |
| Financing Cash Flow | -$327K | +0.0% | — |
| +71.4% |
| +80.0% |
| EPS (Diluted) | -$0.06 | +71.4% | +80.0% |
| $62.8M |
| -1.2% |
| +11.9% |